Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries

Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries

Abstract Background There is a high unmet need among patients with treatment-resistant depression (TRD) as treatment with standard therapies is associated with low response and remission rates and high rates of relapse. Esketamine nasal spray, an N-methyl-D-aspartate receptor antagonist, is a novel,...

Full description

Bibliographic Details
Main Authors: Nahida Nayaz Ahmed, Faisal Albishi, Suhail A. Khan, Ammar Alsayegh, Emmanuel Stip, Samer Makhoul
Format: Article
Language:English
Published: SpringerOpen 2023-12-01
Series:Middle East Current Psychiatry
Subjects:
Esketamine nasal spray
Treatment-resistant depression
Major depressive disorder
Gulf Cooperation Council
Online Access:https://doi.org/10.1186/s43045-023-00369-3

Similar Items

Similar Items